Pulmonary Rehabilitation After Minimal Invasive Surgery in Lung Cancer
NCT ID: NCT05136300
Last Updated: 2022-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2019-05-01
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Post-thoracotomy Pulmonary Rehabilitation on Quality of Life
NCT00460668
Lung Rehabilitation in Treating Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Surgery for Lung Cancer
NCT00363428
Effect of Pulmonary Rehabilitation in Lung Cancer Survivors
NCT01246297
Pulmonary Rehabilitation Before Lung Cancer Resection
NCT01682850
Early Versus Delayed Rehabilitation Intervention in Patients With Lung Cancer
NCT06051136
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
An integrated multidisciplinary rehabilitation program on general quality of life (short form 36, SF-36, subdomain general health) in the 12 months postoperative period in patients undergoing elective minimal invasive surgery in lung cancer
Pulmonary rehabilitation
Patients in the intervention group will receive physical therapy, scheduled pain monitoring and coaching by a social worker.
The intensity of the rehabilitation training program will be determined separately for each patient by a steepramp and 1-repetition test within 3 weeks post-operative. The intervention group will be trained and educated in 2 sessions of 2 hours per week, for a period of 3 months.
Control
Standard of care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulmonary rehabilitation
Patients in the intervention group will receive physical therapy, scheduled pain monitoring and coaching by a social worker.
The intensity of the rehabilitation training program will be determined separately for each patient by a steepramp and 1-repetition test within 3 weeks post-operative. The intervention group will be trained and educated in 2 sessions of 2 hours per week, for a period of 3 months.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age between 18 and 80 years.
3. ECOG 0 - 2 post-surgery.
Exclusion Criteria
2. Previous pulmonary surgery
3. Comorbidity limiting rehabilitation
1. Rheumatoid arthritis
2. Severe ischaemic heart disease or myocardial failure; EF ≤ 35 %.
3. Muscle disease
4. Fibromyalgia
5. Neurologic disorders (Parkinson disease, CVA and lesions of the spinal cord)
6. Psychiatric disorders
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Isala
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lars Dinjens
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
J Stigt
Role: PRINCIPAL_INVESTIGATOR
Isala
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Isala
Zwolle, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
L Dinjens, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABR 63724
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.